查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1625168

到 2030 年生物製药第三方物流预测：按服务类型、温度类型、运输模式、应用、最终用户和地区进行全球分析

Biopharmaceutical Third-party Logistics Market Forecasts to 2030 - Global Analysis By Service Type, Temperature Type, Mode of Transport, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2024年全球生物製药第三方物流（3PL）市场规模将达到1,252.4亿美元，2030年将达到1,896.2亿美元，预测期内复合年增长率为7.2%。

生物製药第三方物流是指生物製药公司将物流服务外包给专业供应商。这些供应商管理关键的供应链功能，例如仓储、运输、库存管理和生物製药分销。透过利用第三方物流，公司可以降低成本、提高效率并专注于其核心竞争力，同时确保及时、安全地将产品交付给医护人员和患者。

根据2021年7月进行的全球调查，第三方物流供应商的低温运输服务成长了62%。

生物製药需求不断成长

随着全球医疗保健的发展，对处理温度敏感的高价值产品的高效且合规的物流解决方案的需求不断增加。 3PL 供应商提供低温运输物流、合规性和安全运输等专业服务，以确保这些产品的完整性和安全性。此外，生物製药製造的区域扩张增加了对可靠物流网路的需求。这种不断增长的需求正在推动物流基础设施的创新和投资，推动整体市场的扩张。

供应链中断的风险

3PL 的供应链中断风险源自于自然灾害、地缘政治不稳定、劳动力短缺、运输瓶颈和监管变化等因素。这些中断可能导致药物交付延迟、缺货和温度敏感产品变质。对于产品完整性至关重要的生物製药来说，这些破坏可能会产生严重后果。这些风险会增加成本、影响服务可靠性并降低客户信任，从而阻碍市场成长。

生物製药产业的全球化

随着生物製药公司在全球扩张，对产品可靠性、合规性和及时交付的需求不断增长。 3PL 供应商在管理复杂的供应链、确保法规遵循和处理对温度敏感的药品方面发挥关键作用。此外，随着生技药品、疫苗和临床试验材料跨境贸易的增加，3PL 供应商对于克服物流挑战和满足全球对生物製药和市场不断增长的需求至关重要。

保安和安全问题

3PL 中的安全问题源于生物药品价格昂贵且敏感，这使得它们在运输过程中容易被盗窃、伪造和损坏。对温度敏感的药物需要精确处理才能维持功效，任何偏差都会影响产品品质。此外，全球运输可能面临诈骗、货物窃盗和窜改等风险。这些担忧增加了安全措施、监管合规和保险等营运成本，阻碍了市场成长。

COVID-19 的影响

COVID-19大流行增加了对温度敏感药物（尤其是疫苗）的配送需求，对生物製药第三方物流市场产生了重大影响。全球医疗保健需求的激增导致供应链紧张，并凸显了强大的物流解决方案的重要性。儘管运输中断、劳动力短缺和边境限制带来了挑战，但疫情加速了数位技术的采用，以追踪和管理货运。总体而言，COVID-19 凸显了生物製药产业对有弹性、高效且合规的 3PL 服务的需求。

预计在预测期内，仓储业将是最大的。

预计仓储业将在整个预测期内获得最大的市场占有率。生物医药第三方物流仓储包括温度敏感药物、生技药品、疫苗等医药产品的储存。仓储服务对于维持生物製药的品质、安全性和有效性至关重要。生技药品的成长和全球分销正在推动对安全、合规和高效仓储解决方案的需求。

预计临床试验和样本部分在预测期内复合年增长率最高。

预计临床试验和样本部分在预测期内复合年增长率最高。 3PL 提供者确保遵守良好的分销实践和温度控制要求，这对于维持临床实验药物的完整性和有效性至关重要。这些服务包括安全包装、低温运输物流以及及时运送到世界各地的临床实验地点。随着临床试验在全球扩展，3PL 在临床材料的高效、合规且经济高效的管理方面发挥关键作用。

比最大的地区

由于对生物製药（尤其是疫苗和生技药品）的需求不断增长以及对医疗保健基础设施的投资增加，预计亚太地区将在预测期内创下最大的市场占有率。市场的主要参与者包括 DHL Supply Chain、Kuehne+Nagel、DB Schenker、XPO Logistics 等。该地区快速的都市化和监管发展进一步推动了市场的成长。随着低温运输物流需求的增加，亚太地区3PL市场预计将大幅成长，为物流供应商提供新的商机。

复合年增长率最高的地区：

由于北美地区注重监管合规性，预计在预测期内复合年增长率最高。该地区拥有完善的医疗保健基础设施，生技药品和生物相似药的成长进一步推动了市场。该地区的主要企业包括 FedEx、UPS、XPO Logistics 和 Kuehne+Nagel。随着对低温运输物流的日益关注，在对高效、合规的生物製药分销解决方案的需求的推动下，北美 3PL 市场预计将出现强劲增长。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球生物製药第三方物流市场：依服务类型

  • 运输管理
  • 仓储
  • 库存管理
  • 包裹
  • 订单履行
  • 报关
  • 退货管理
  • 其他服务类型

第六章全球生物製药第三方物流市场：依温度类型

  • 环境的
  • 低温运输
  • 冷冻的
  • 其他温度类型

第七章 全球生物製药第三方物流市场：依运输方式划分

  • 道路运输
  • 铁路运输
  • 空运
  • 海运

第八章全球生物製药第三方物流市场：依应用

  • 低温运输物流
  • 非低温运输物流
  • 临床试验和样品
  • 成品
  • 其他用途

第九章全球生物製药第三方物流市场：依最终用户分类

  • 药品製造商
  • 生技公司
  • 合约药物开发业务（CRO）
  • 药品契约製造(CMO)
  • 医疗服务提供方
  • 其他最终用户

第十章全球生物製药第三方物流市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章 公司概况

  • DHL Supply Chain
  • Kuehne+Nagel
  • UPS Supply Chain Solutions
  • FedEx Supply Chain
  • XPO Logistics
  • CH Robinson Worldwide
  • DB Schenker
  • Expeditors International
  • Hellmann Worldwide Logistics
  • Sinotrans Limited
  • DSV A/S
  • Agility Logistics
  • Seino Transportation
  • Ceva Logistics
  • Alcami Corporation
Product Code: SMRC28121

According to Stratistics MRC, the Global Biopharmaceutical Third-party Logistics Market is accounted for $125.24 billion in 2024 and is expected to reach $189.62 billion by 2030 growing at a CAGR of 7.2% during the forecast period. Biopharmaceutical third-party logistics refers to the outsourcing of logistics services by biopharmaceutical companies to specialized providers. These providers manage key supply chain functions such as warehousing, transportation, inventory management, and distribution of biopharmaceutical products. By leveraging third-party logistics, companies can reduce costs, improve efficiency, and focus on their core competencies while ensuring timely and safe delivery of products to healthcare providers and patients.

According to a global survey carried out in July 2021, cold chain services by third-party logistics providers raised by 62%.

Market Dynamics:

Driver:

Rising demand for biopharmaceutical products

As the global healthcare landscape evolves, the need for efficient and compliant logistics solutions to handle temperature-sensitive and high-value products increases. 3PL providers offer specialized services such as cold chain logistics, regulatory compliance, and secure transportation, ensuring the integrity and safety of these products. Additionally, the expansion of biopharmaceutical manufacturing across regions boosts the need for reliable distribution networks. This growing demand drives innovation and investment in logistics infrastructure, fostering the market's overall expansion.

Restraint:

Risk of supply chain disruptions

The risk of supply chain disruptions in 3PL arises from factors like natural disasters, geopolitical instability, labor shortages, transportation bottlenecks, and regulatory changes. These disruptions can lead to delays in drug delivery, stockouts, and spoilage of temperature-sensitive products. For biopharmaceuticals, where product integrity is critical, such interruptions can have serious consequences. These risks hinder market growth by increasing costs, impacting service reliability, and reducing customer trust.

Opportunity:

Globalization of the biopharmaceutical industry

With the rising global footprint of biopharmaceutical companies, the demand for reliable, compliant, and timely delivery of products rises. 3PL providers play a crucial role in managing complex supply chains, ensuring regulatory adherence, and handling temperature-sensitive drugs. Furthermore, with the rise in cross-border trade of biologics, vaccines, and clinical trial materials, 3PL providers are essential for overcoming logistical challenges and meeting the growing global demand for biopharmaceutical products, fostering market growth.

Threat:

Security and safety concerns

Security and safety concerns in 3PL arise from the high value and sensitivity of biopharmaceutical products, which are vulnerable to theft, counterfeiting, and damage during transit. Temperature-sensitive drugs require precise handling to maintain efficacy, and any deviation can compromise product quality. Additionally, global transportation can face risks from fraud, cargo theft, or tampering. These concerns hamper market growth by increasing operational costs for security measures, regulatory compliance and insurance.

Covid-19 Impact

The covid-19 pandemic significantly impacted the biopharmaceutical third-party logistics market by increasing demand for temperature-sensitive drug distribution, especially vaccines. The surge in global healthcare needs strained supply chains, highlighting the importance of robust logistics solutions. While disruptions in transportation, labor shortages, and border restrictions posed challenges, the pandemic also accelerated the adoption of digital technologies for tracking and managing shipments. Overall, COVID-19 emphasized the need for resilient, efficient, and compliant 3PL services in the biopharmaceutical industry.

The warehousing segment is expected to be the largest during the forecast period

The warehousing segment is predicted to secure the largest market share throughout the forecast period. Warehousing in biopharmaceutical third-party logistics involves the storage of pharmaceutical products, including temperature-sensitive drugs, biologics, and vaccines. Warehousing services are critical for maintaining the quality, safety, and efficacy of biopharmaceuticals. The growth of biologics and global distribution has expanded the demand for secure, compliant, and efficient warehousing solutions.

The clinical trials & samples segment is expected to have the highest CAGR during the forecast period

The clinical trials & samples segment is anticipated to witness the highest CAGR during the forecast period. 3PL providers ensure compliance with good distribution practice and temperature control requirements, crucial for maintaining the integrity and efficacy of trial materials. These services include secure packaging, cold chain logistics, and timely delivery to trial sites worldwide. As clinical trials expand globally, 3PL plays a vital role in efficient, compliant, and cost-effective management of clinical materials.

Region with largest share:

Asia Pacific is expected to register the largest market share during the forecast period driven by growing demand for biopharmaceuticals, especially vaccines and biologics, along with increasing investments in healthcare infrastructure. Key players in this market include DHL Supply Chain, Kuehne + Nagel, DB Schenker, and XPO Logistics. The region's rapid urbanization and regulatory advancements further support market growth. As demand for cold chain logistics rises, the Asia-Pacific 3PL market is expected to grow significantly, offering new opportunities for logistics providers.

Region with highest CAGR:

North America is expected to witness the highest CAGR over the forecast period fuelled by its strong emphasis on regulatory compliance. The region's well-established healthcare infrastructure and the growth of biologics and biosimilars further propel the market. Key players in the region include FedEx, UPS, XPO Logistics, and Kuehne + Nagel. With an expanding focus on cold chain logistics, North America's 3PL market is expected to experience steady growth, driven by the need for efficient and compliant biopharmaceutical distribution solutions.

Key players in the market

Some of the key players profiled in the Biopharmaceutical Third-party Logistics Market include DHL Supply Chain, Kuehne + Nagel, UPS Supply Chain Solutions, FedEx Supply Chain, XPO Logistics, C.H. Robinson Worldwide, DB Schenker, Expeditors International, Hellmann Worldwide Logistics, Sinotrans Limited, DSV A/S, Agility Logistics, Seino Transportation, Ceva Logistics and Alcami Corporation.

Key Developments:

In January 2024, Alcami Corporation opened a new 65,000 ft2 pharmaceutical storage and services facility in Garner, North Carolina, strategically located near the Research Triangle Park (RTP), a major biotech and pharmaceutical hub. This state-of-the-art facility is part of Alcami's plan to enhance its contract development and manufacturing services, providing specialized storage solutions for biotech and pharmaceutical clients.

In August 2023, CEVA Logistics expanded its operations in India by acquiring 96% of Stellar Value Chain Solutions, a Mumbai-based provider of contract logistics and omni-channel fulfilment services. This strategic acquisition enhances CEVA's presence in India, adding over 60 locations across 35 cities. The deal also boosts CEVA's capabilities in sectors like e-commerce, automotive, consumer products, and pharmaceuticals.

Service Types Covered:

  • Transportation Management
  • Warehousing
  • Inventory Management
  • Packaging
  • Order Fulfillment
  • Customs Clearance
  • Returns Management
  • Other Service Types

Temperature Types Covered:

  • Ambient
  • Cold Chain
  • Frozen
  • Other Temperature Types

Mode of Transports Covered:

  • Road Transport
  • Rail Transport
  • Air Transport
  • Sea Transport

Applications Covered:

  • Cold Chain Logistics
  • Non-Cold Chain Logistics
  • Clinical Trials & Samples
  • Finished Goods
  • Other Applications

End Users Covered:

  • Pharmaceutical Manufacturers
  • Biotech Companies
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs)
  • Healthcare Providers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biopharmaceutical Third-party Logistics Market, By Service Type

  • 5.1 Introduction
  • 5.2 Transportation Management
  • 5.3 Warehousing
  • 5.4 Inventory Management
  • 5.5 Packaging
  • 5.6 Order Fulfillment
  • 5.7 Customs Clearance
  • 5.8 Returns Management
  • 5.9 Other Service Types

6 Global Biopharmaceutical Third-party Logistics Market, By Temperature Type

  • 6.1 Introduction
  • 6.2 Ambient
  • 6.3 Cold Chain
  • 6.4 Frozen
  • 6.5 Other Temperature Types

7 Global Biopharmaceutical Third-party Logistics Market, By Mode of Transport

  • 7.1 Introduction
  • 7.2 Road Transport
  • 7.3 Rail Transport
  • 7.4 Air Transport
  • 7.5 Sea Transport

8 Global Biopharmaceutical Third-party Logistics Market, By Application

  • 8.1 Introduction
  • 8.2 Cold Chain Logistics
  • 8.3 Non-Cold Chain Logistics
  • 8.4 Clinical Trials & Samples
  • 8.5 Finished Goods
  • 8.6 Other Applications

9 Global Biopharmaceutical Third-party Logistics Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical Manufacturers
  • 9.3 Biotech Companies
  • 9.4 Contract Research Organizations (CROs)
  • 9.5 Contract Manufacturing Organizations (CMOs)
  • 9.6 Healthcare Providers
  • 9.7 Other End Users

10 Global Biopharmaceutical Third-party Logistics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 DHL Supply Chain
  • 12.2 Kuehne + Nagel
  • 12.3 UPS Supply Chain Solutions
  • 12.4 FedEx Supply Chain
  • 12.5 XPO Logistics
  • 12.6 C.H. Robinson Worldwide
  • 12.7 DB Schenker
  • 12.8 Expeditors International
  • 12.9 Hellmann Worldwide Logistics
  • 12.10 Sinotrans Limited
  • 12.11 DSV A/S
  • 12.12 Agility Logistics
  • 12.13 Seino Transportation
  • 12.14 Ceva Logistics
  • 12.15 Alcami Corporation

List of Tables

  • Table 1 Global Biopharmaceutical Third-party Logistics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Biopharmaceutical Third-party Logistics Market Outlook, By Service Type (2022-2030) ($MN)
  • Table 3 Global Biopharmaceutical Third-party Logistics Market Outlook, By Transportation Management (2022-2030) ($MN)
  • Table 4 Global Biopharmaceutical Third-party Logistics Market Outlook, By Warehousing (2022-2030) ($MN)
  • Table 5 Global Biopharmaceutical Third-party Logistics Market Outlook, By Inventory Management (2022-2030) ($MN)
  • Table 6 Global Biopharmaceutical Third-party Logistics Market Outlook, By Packaging (2022-2030) ($MN)
  • Table 7 Global Biopharmaceutical Third-party Logistics Market Outlook, By Order Fulfillment (2022-2030) ($MN)
  • Table 8 Global Biopharmaceutical Third-party Logistics Market Outlook, By Customs Clearance (2022-2030) ($MN)
  • Table 9 Global Biopharmaceutical Third-party Logistics Market Outlook, By Returns Management (2022-2030) ($MN)
  • Table 10 Global Biopharmaceutical Third-party Logistics Market Outlook, By Other Service Types (2022-2030) ($MN)
  • Table 11 Global Biopharmaceutical Third-party Logistics Market Outlook, By Temperature Type (2022-2030) ($MN)
  • Table 12 Global Biopharmaceutical Third-party Logistics Market Outlook, By Ambient (2022-2030) ($MN)
  • Table 13 Global Biopharmaceutical Third-party Logistics Market Outlook, By Cold Chain (2022-2030) ($MN)
  • Table 14 Global Biopharmaceutical Third-party Logistics Market Outlook, By Frozen (2022-2030) ($MN)
  • Table 15 Global Biopharmaceutical Third-party Logistics Market Outlook, By Other Temperature Types (2022-2030) ($MN)
  • Table 16 Global Biopharmaceutical Third-party Logistics Market Outlook, By Mode of Transport (2022-2030) ($MN)
  • Table 17 Global Biopharmaceutical Third-party Logistics Market Outlook, By Road Transport (2022-2030) ($MN)
  • Table 18 Global Biopharmaceutical Third-party Logistics Market Outlook, By Rail Transport (2022-2030) ($MN)
  • Table 19 Global Biopharmaceutical Third-party Logistics Market Outlook, By Air Transport (2022-2030) ($MN)
  • Table 20 Global Biopharmaceutical Third-party Logistics Market Outlook, By Sea Transport (2022-2030) ($MN)
  • Table 21 Global Biopharmaceutical Third-party Logistics Market Outlook, By Application (2022-2030) ($MN)
  • Table 22 Global Biopharmaceutical Third-party Logistics Market Outlook, By Cold Chain Logistics (2022-2030) ($MN)
  • Table 23 Global Biopharmaceutical Third-party Logistics Market Outlook, By Non-Cold Chain Logistics (2022-2030) ($MN)
  • Table 24 Global Biopharmaceutical Third-party Logistics Market Outlook, By Clinical Trials & Samples (2022-2030) ($MN)
  • Table 25 Global Biopharmaceutical Third-party Logistics Market Outlook, By Finished Goods (2022-2030) ($MN)
  • Table 26 Global Biopharmaceutical Third-party Logistics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 27 Global Biopharmaceutical Third-party Logistics Market Outlook, By End User (2022-2030) ($MN)
  • Table 28 Global Biopharmaceutical Third-party Logistics Market Outlook, By Pharmaceutical Manufacturers (2022-2030) ($MN)
  • Table 29 Global Biopharmaceutical Third-party Logistics Market Outlook, By Biotech Companies (2022-2030) ($MN)
  • Table 30 Global Biopharmaceutical Third-party Logistics Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)
  • Table 31 Global Biopharmaceutical Third-party Logistics Market Outlook, By Contract Manufacturing Organizations (CMOs) (2022-2030) ($MN)
  • Table 32 Global Biopharmaceutical Third-party Logistics Market Outlook, By Healthcare Providers (2022-2030) ($MN)
  • Table 33 Global Biopharmaceutical Third-party Logistics Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.